# Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab

> **NCT03056924** · — · COMPLETED · sponsor: **Boston Medical Center** · enrollment: 173 (actual)

## Conditions studied

- Inflammatory Bowel Diseases

## Interventions

- **BIOLOGICAL:** Pneumococcal Pneumonia vaccine
- **BIOLOGICAL:** Influenza vaccine
- **BIOLOGICAL:** Hepatitis B vaccine

## Key facts

- **NCT ID:** NCT03056924
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-05
- **Primary completion:** 2019-01-15
- **Final completion:** 2019-01-15
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2019-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03056924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03056924, "Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03056924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*